Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors
about
Targeting interleukin-2-inducible T-cell kinase (ITK) and resting lymphocyte kinase (RLK) using a novel covalent inhibitor PRN694.Discovery of a novel allosteric inhibitor-binding site in ERK5: comparison with the canonical kinase hinge ATP-binding site.Targeting Interleukin-2-Inducible T-cell Kinase (ITK) in T-Cell Related Diseases.Inducible tyrosine kinase inhibitors: a review of the patent literature (2010 - 2013).Quantitative monitoring of two simultaneously binding species using Label-Enhanced surface plasmon resonance.
P2860
Selectively targeting an inactive conformation of interleukin-2-inducible T-cell kinase by allosteric inhibitors
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Selectively targeting an inact ...... inase by allosteric inhibitors
@ast
Selectively targeting an inact ...... inase by allosteric inhibitors
@en
Selectively targeting an inact ...... inase by allosteric inhibitors
@nl
type
label
Selectively targeting an inact ...... inase by allosteric inhibitors
@ast
Selectively targeting an inact ...... inase by allosteric inhibitors
@en
Selectively targeting an inact ...... inase by allosteric inhibitors
@nl
prefLabel
Selectively targeting an inact ...... inase by allosteric inhibitors
@ast
Selectively targeting an inact ...... inase by allosteric inhibitors
@en
Selectively targeting an inact ...... inase by allosteric inhibitors
@nl
P2093
P2860
P356
P1433
P1476
Selectively targeting an inact ...... inase by allosteric inhibitors
@en
P2093
Andrew Cook
Ann Aulabaugh
Chris Phillips
Chulho Choi
Colin Robinson
David C Limburg
David R Anderson
Francis Rajamohan
Iva Navratilova
P2860
P304
P356
10.1042/BJ20131139
P407
P50
P577
2014-06-01T00:00:00Z